Emixustat hydrochloride
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Emixustat hydrochloride, covering 2017-07-02 to 2021-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease [Phase 2]